EyePoint Pharmaceuticals, Inc. — Director's Dealing 2020

Jun 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EyePoint Pharmaceuticals, Inc. (EYPT)
CIK: 0001314102
Period of Report: 2020-06-27

Reporting Person: Paggiarino Dario A. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-27	Common Stock	M	10000.00	$0.00	Acquired	63079.00	Direct
2020-06-27	Common Stock	F	2936.00	$0.789	Disposed	60143.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-27	Restricted Stock Units	$0.00	M	10000.00	Disposed		Common Stock (10000.00)	Direct

Footnotes

F1: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units

F2: On June 27, 2017, the reporting person was granted 30,000 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.